Author:
Cantú Silvana M.,Rosón María I.,Donoso Adriana S.,Puyó Ana M.,Choi Marcelo R.
Publisher
Springer International Publishing
Reference13 articles.
1. Cantú SM, Donoso AS, Kouyoumdzian NM, Rukavina Mikusic NL, Puyó AM, et al. Clinical aspects of C-Type natriuretic peptide on the cardiovascular system. Int J Clin Endocrinol Metab. 2015;1(2):31–6.
2. Garbers DL. Guanylyl cyclase receptors and their endocrine, paracrine, and autocrine ligands. Cell. 1992;71(1):1–4.
3. Garbers DL, Chrisman TD, Wiegn P, Katafuchi T, Albanesi JP, Bielinski V, et al. Membrane guanylyl cyclase receptors: an update. Trends Endocrinol Metab. 2006;17(6):251–8.
4. Khurana ML, Pandey KN. Receptor-mediated stimulatory effect of atrial natriuretic factor, brain natriuretic peptide, and C-type natriuretic peptide on testosterone production in purified mouse Leydig cells: activation of cholesterol side-chain cleavage enzyme. Endocrinology. 1993;133(5):2141–9.
5. Koller KJ, Goeddel DV. Molecular biology of the natriuretic peptides and their receptors. Circulation. 1992;86(4):1081–8.